Semaglutide is mostly well tolerated with equivalent dropout prices compared with placebo, even though it could possibly be considerably less nicely tolerated than dulaglutide (Trulicity).1,3 The most common adverse outcomes are nausea, vomiting, and diarrhea and can be knowledgeable by about 30% of patients, typically once the dose is greater.On a